![](/img/cover-not-exists.png)
Biweekly Doxorubicin/Ketoconazole as Second-Line Treatment in Docetaxel-Resistant, Hormone-Refractory Prostate Cancer
George Lainakis, Antoniou Nikos, Alivizatos Gerassimos, Chrisofos Michael, Mitsoyiannis Iraklis, Livadas Konstantinos, Varkarakis Ioannis, Katsifotis Harilaos, Meletios A. Dimopoulos, Aristotelis BamiVolume:
71
Year:
2008
Language:
english
DOI:
10.1016/j.urology.2008.02.048
File:
PDF, 80 KB
english, 2008